Mei-Ling Ai

732 total citations
14 papers, 505 citations indexed

About

Mei-Ling Ai is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Mei-Ling Ai has authored 14 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Mei-Ling Ai's work include Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (3 papers) and Peptidase Inhibition and Analysis (2 papers). Mei-Ling Ai is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (3 papers) and Peptidase Inhibition and Analysis (2 papers). Mei-Ling Ai collaborates with scholars based in China and United States. Mei-Ling Ai's co-authors include Yiqing Wang, Li Zhao, Shuang Wang, Jiang Yu, Huanan Wang, Yue Han, Shasha Hu, Lan Wang, Huijuan Jiang and Minhui Yang and has published in prestigious journals such as Cancer Research, Oncogene and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Mei-Ling Ai

14 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mei-Ling Ai China	11	370	282	97	75	67	14	505
Kai‐Yu Ng Hong Kong	9	402 1.1×	235 0.8×	130 1.3×	43 0.6×	46 0.7×	11	542
Hee Doo Yang South Korea	13	479 1.3×	279 1.0×	80 0.8×	46 0.6×	42 0.6×	18	607
Dian-na Gu China	12	306 0.8×	282 1.0×	151 1.6×	60 0.8×	70 1.0×	27	516
Megan Roche United States	8	256 0.7×	246 0.9×	100 1.0×	33 0.4×	67 1.0×	11	422
Nicole P. Ho Hong Kong	6	265 0.7×	213 0.8×	137 1.4×	43 0.6×	65 1.0×	9	453
Yuntan Qiu China	12	476 1.3×	365 1.3×	72 0.7×	50 0.7×	39 0.6×	19	596
Yuandong Liao China	11	337 0.9×	320 1.1×	90 0.9×	26 0.3×	46 0.7×	19	499
Yuli Jia China	13	408 1.1×	279 1.0×	123 1.3×	50 0.7×	53 0.8×	14	567
Tinghua Hu China	12	280 0.8×	148 0.5×	138 1.4×	39 0.5×	76 1.1×	35	461
Meisongzhu Yang China	12	386 1.0×	220 0.8×	104 1.1×	26 0.3×	63 0.9×	16	524

Countries citing papers authored by Mei-Ling Ai

Since Specialization

Citations

This map shows the geographic impact of Mei-Ling Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei-Ling Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei-Ling Ai more than expected).

Fields of papers citing papers by Mei-Ling Ai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei-Ling Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei-Ling Ai. The network helps show where Mei-Ling Ai may publish in the future.

Co-authorship network of co-authors of Mei-Ling Ai

This figure shows the co-authorship network connecting the top 25 collaborators of Mei-Ling Ai. A scholar is included among the top collaborators of Mei-Ling Ai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei-Ling Ai. Mei-Ling Ai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Xie, Lifen, Mei-Ling Ai, An He, et al.. (2024). Spatial Proteomic Profiling of Colorectal Cancer Revealed Its Tumor Microenvironment Heterogeneity. Journal of Proteome Research. 23(8). 3342–3352. 3 indexed citations

Ai, Mei-Ling, Yuan Zhan, Qinghua Hu, et al.. (2024). TRIM14 suppressed the progression of NSCLC via hexosamine biosynthesis pathway. Carcinogenesis. 45(5). 324–336. 3 indexed citations

Tian, Yunhong, Mei-Ling Ai, Chunshan Liu, et al.. (2023). Upregulated Long Non-coding RNA Lnc-MRPL39-2:1 Induces the Growth and Invasion of Nasopharyngeal Carcinoma by Binding to HuR and Stabilizing β-Catenin mRNA. International Journal of Biological Sciences. 19(8). 2349–2365. 5 indexed citations

Khan, Muhammad, Kunpeng Du, Mei-Ling Ai, et al.. (2023). PD-L1 expression as biomarker of efficacy of PD-1/PD-L1 checkpoint inhibitors in metastatic triple negative breast cancer: A systematic review and meta-analysis. Frontiers in Immunology. 14. 1060308–1060308. 24 indexed citations

Tian, Yunhong, Chunshan Liu, Zhiyong Li, et al.. (2022). Exosomal B7–H4 from irradiated glioblastoma cells contributes to increase FoxP3 expression of differentiating Th1 cells and promotes tumor growth. Redox Biology. 56. 102454–102454. 29 indexed citations

Khan, Muhammad, Mei-Ling Ai, Kunpeng Du, et al.. (2022). Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective. Frontiers in Immunology. 13. 1062225–1062225. 38 indexed citations

Wang, Baiyao, Xiaoting Huang, Hongli Yang, et al.. (2021). PLK1 Inhibition Sensitizes Breast Cancer Cells to Radiation via Suppressing Autophagy. International Journal of Radiation Oncology*Biology*Physics. 110(4). 1234–1247. 42 indexed citations

Yang, Fang, Yong Li, Qinghua Hu, et al.. (2021). AIMP3 inhibits cell growth and metastasis of lung adenocarcinoma through activating a miR‐96‐5p‐AIMP3‐p53 axis. Journal of Cellular and Molecular Medicine. 25(6). 3019–3030. 10 indexed citations

Tian, Yunhong, Yunming Tian, Yinuo Tu, et al.. (2020). microRNA‐124 inhibits stem‐like properties and enhances radiosensitivity in nasopharyngeal carcinoma cells via direct repression of expression of JAMA. Journal of Cellular and Molecular Medicine. 24(17). 9533–9544. 15 indexed citations

10.

Wang, Lan, Mei-Ling Ai, Li Zhao, et al.. (2020). EHF promotes colorectal carcinoma progression by activating TGF‐β1 transcription and canonical TGF‐β signaling. Cancer Science. 111(7). 2310–2324. 17 indexed citations

11.

Wang, Yiqing, Dongmei Jiang, Shasha Hu, et al.. (2019). SATB2-AS1 Suppresses Colorectal Carcinoma Aggressiveness by Inhibiting SATB2-Dependent Snail Transcription and Epithelial–Mesenchymal Transition. Cancer Research. 79(14). 3542–3556. 74 indexed citations

12.

Yang, Minhui, Li Zhao, Lan Wang, et al.. (2019). Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling. Molecular Cancer. 18(1). 31–31. 82 indexed citations

13.

Wang, Huanan, Guangxu Deng, Mei-Ling Ai, et al.. (2018). Hsp90ab1 stabilizes LRP5 to promote epithelial–mesenchymal transition via activating of AKT and Wnt/β-catenin signaling pathways in gastric cancer progression. Oncogene. 38(9). 1489–1507. 83 indexed citations

14.

Jiang, Huijuan, Yiqing Wang, Mei-Ling Ai, et al.. (2017). Long noncoding RNA CRNDE stabilized by hnRNPUL2 accelerates cell proliferation and migration in colorectal carcinoma via activating Ras/MAPK signaling pathways. Cell Death and Disease. 8(6). e2862–e2862. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact